Case guide

UPDATED FEB 2026

PowerPort vs. Other Port Catheters — Key Differences

Part of the Bard PowerPort Catheter investigation

The short answer

The Bard PowerPort's polyurethane catheter is the defining design characteristic that distinguishes it from safer alternatives like Hickman catheters, silicone Mediport devices, and PICC lines — none of which use polyurethane tubing and none of which carry the same environmental stress cracking fracture risk.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Understanding Different Types of Venous Access Devices

Patients requiring long-term intravenous access for chemotherapy, nutrition, or repeated blood draws have several device options. Implantable ports — placed entirely under the skin — offer the advantage of no external tubing and can remain in place for years. Tunneled catheters such as Hickman and Broviac catheters exit through the skin and require daily maintenance. Peripherally inserted central catheters (PICC lines) are placed through arm veins and are intended for shorter-term use (weeks to months). The choice between these devices involves trade-offs in convenience, maintenance burden, infection risk, and longevity.

The Bard PowerPort is specifically a power-injectable port — meaning it is engineered to withstand the high injection pressures of CT contrast administration (up to 5 mL/sec) as well as standard infusion. This power-injection capability was a differentiating marketing feature. The polyurethane catheter tubing was chosen to provide the structural rigidity needed to withstand power injection forces. Competing silicone catheters in standard implantable ports are not power-injectable at standard pressures, though power-injectable silicone port catheters have since been developed and marketed.

Hickman Catheter

Hickman catheters (and the related Broviac catheter) are tunneled, externally-exiting central venous catheters made from silicone tubing. The catheter is tunneled under the chest skin but exits through the skin, with the external portion requiring a sterile dressing and daily heparin flushing by the patient or caregiver. Because there is no implanted port, there is no subcutaneous reservoir and no access needle required. Hickman catheters use silicone tubing throughout — they do not experience the ESC fracture mechanism that affects polyurethane PowerPort catheters. However, their external exposure creates different risks: higher infection rates from the skin exit site and accidental dislodgement.

Silicone Mediport and Other Implantable Ports

Several manufacturers produce implantable ports with silicone catheter tubing — including certain Vortex Port and Titanium Port products from AngioDynamics and others. These silicone-catheter ports provide the same subcutaneous convenience as the PowerPort — no external hardware, accessed only when needed — while using catheter tubing that does not degrade through the ESC mechanism that fractures polyurethane. Plaintiffs in the PowerPort litigation argue that the existence of silicone-catheter implantable ports demonstrates that a safer design alternative was available and feasible when Bard chose to use polyurethane.

PICC Lines

Peripherally inserted central catheters (PICCs) are inserted through a peripheral arm vein (typically the basilic or cephalic vein) and advanced until the tip rests in the superior vena cava. They are intended for short to medium-term use (weeks to several months) and are commonly used in patients who need central venous access but do not warrant a permanent implantable port. PICCs use polyurethane or silicone tubing; polyurethane PICC fractures have been reported but are generally less common than PowerPort fractures due to shorter implant durations. PICCs exit through the arm skin and require maintenance. They do not involve the clavicle-first rib pinch-off mechanism that is a primary driver of PowerPort fracture because the insertion site and catheter routing are different.

Key data

Data & Statistics

2 SOURCED FIGURES

Power-injection capability (up to 5 mL/sec) was a key marketing feature of the PowerPort that drove use of stiffer polyurethane rather than silicone tubing

Bard PowerPort product materials / MDL documents

Silicone catheters have not shown the same ESC degradation pattern as polyurethane in long-term implant studies

Journal of Biomedical Materials Research, 2018

FAQ

Frequently Asked Questions

12 QUESTIONS

A Bard PowerPort is a brand of implantable venous access port (IVAP) made by C.R. Bard (now part of Becton Dickinson). It consists of a small reservoir implanted under the chest skin connected to a polyurethane catheter threaded into a large central vein near the heart. The device provides long-term intravenous access for chemotherapy, blood draws, and medication delivery without repeated needle sticks. Millions of patients have received PowerPort devices, with cancer patients being the primary recipients. The defect at the center of current litigation is the polyurethane catheter's susceptibility to fracturing inside the body over time.

Dive deeper

Related Guides

9 GUIDES

The full investigation

Part of the Bard PowerPort Catheter Investigation